Cowen reiterated an Outperform rating on Zafgen (NASDAQ: ZFGN), and cut the price target to $20.00 (from $60.00), following FDA'a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

RBC Capital Sees Attractive Risk/Reward in Zafgen (ZFGN)October 19, 2015 10:13 AM UPDATE: FBR Downgrades Zafgen (ZFGN) to Sector PerformOctober 16, 2015 2:56 PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Zafgen Inc. and Encourages Investors to Contact the Firm (ZFGN)October 16, 2015 1:19 PM Unusual 11 Mid-Day Movers 10/16: (YOKU) (SFXE) (YGE) Higher; (ZFGN) (CEMP) (PWR) LowerOctober 16, 2015 12:54 PM Streetinsider.com's Hot Lunchtime Reads 10/16: (AAPL) (TWTR) (PTCT) (ZFGN)October 16, 2015 12:09 PM Zafgen (ZFGN) PT Cut to $46 at Leerink Partners Amid Partial Clinical Hold; Maintains Bullish ViewOctober 16, 2015 12:07 PM Pre-Open Stock Movers 10/16: (SFXE) (YOKU) (BOX) Higher; (ZFGN) (CEMP) (WYNN) LowerOctober 16, 2015 9:39 AM Wall St. closes up, registers third week of gainsOctober 16, 2015 7:26 AM Zafgen's (ZFGN) Beloranib Placed on Partial Clinical Hold by FDAOctober 16, 2015 6:31 AM Zafgen Announces Partial Clinical Hold Affecting Beloranib TrialsOctober 16, 2015 6:30 AM Zafgen (ZFGN) PT Lowered to $46 at RBC Capital; Discusses Road Ahead for BeloranibOctober 15, 2015 7:17 AM Zafgen (ZFGN) PT Cut to $48 at FBR Capital on Patient DeathOctober 15, 2015 6:39 AM Market Wrap: Wal-mart Outlook Pressures Stocks; Square Files for IPO; Netflix Slumps on Light Sub AdditionsOctober 14, 2015 5:28 PM RBC Sees 33% of Zafgen (ZFGN) Death Happening in Placebo Arm; Reiterates 'Outperform' RatingOctober 14, 2015 2:48 PM Leerink Partners Comments on Zafgen (ZFGN) Following Patient DeathOctober 14, 2015 2:26 PM Zafgen (ZFGN) Stock Expected to Languish Until More is Known - CowenOctober 14, 2015 2:20 PM Zafgen (ZFGN) Worst Case Scenario Avoided, RBC Capital - BloombergOctober 14, 2015 1:18 PM Who Traded Zafgen (ZFGN) on Illegal Insider Information?October 14, 2015 12:54 PM Streetinsider.com's Hot Lunchtime Reads 10/14: (WMT) (ZFGN) (TRIP) (SRPT)October 14, 2015 12:35 PM Zafgen (ZFGN) triggers limit-up, limit-down trading pauseOctober 14, 2015 12:31 PM Zafgen (ZFGN) Learns of Death in Beloranib Phase 3October 14, 2015 12:27 PM Zafgen (ZFGN) will resume trading at 12:30pm ETOctober 14, 2015 12:21 PM Zafgen (ZFGN) Issues Statement; FDA Initiates Discussion Following Phase 3 bestPWS DeathOctober 14, 2015 12:01 PM Zafgen Issues StatementOctober 14, 2015 11:59 AM Zafgen (ZFGN) Halted, News PendingOctober 14, 2015 11:48 AM Zafgen (ZFGN) Reportedly Defended at SuntrustOctober 14, 2015 11:00 AM Zafgen (ZFGN) Sees Green-to-Red ReversalOctober 14, 2015 10:19 AM Pre-Open Stock Movers 10/14: (TRIP) (CASI) (SNDK) Higher; (CPHD) (CFX) (DOC) Lower (more...)October 14, 2015 9:31 AM Zafgen (ZFGN) Ticks Higher Early Following Sharp DropOctober 14, 2015 8:49 AM